By Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. | Last revised: 31 December 2011
In children 6 weeks through 5 years of age (prior to the 6th birthday). Prevnar 13 is a vaccine indicated for: active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14,…
By Grifols Biologicals Inc. | Last revised: 31 December 2011
AlphaNine SD is indicated for the prevention and control of bleeding in patients with Factor IX deficiency due to hemophilia B. AlphaNine SD contains low, non-therapeutic levels of Factors II. VII, and X, and, therefore, is not indicated for the…
By Jubilant HollisterStier LLC | Last revised: 31 December 2011
Certain diagnostics carry labeling which states Allergenic Extract for Diagnostic Use Only. Data to support the therapeutic use of products labeled with this statement have not been established. 14 In addition to a carefully taken history, the use…
By CutisPharma, Inc. | Last revised: 29 December 2011
Each FIRST® – Lansoprazole Compounding Kit is comprised of 0.27 grams of lansoprazole powder USP and 90 mL of FIRST® – PPI Suspension containing benzyl alcohol. FD&C red # 40, flavor, hydroxyethylcellulose, purified water, saccharin sodium,…
By CSL Behring GmbH | Last revised: 19 December 2011
RiaSTAP ®. Fibrinogen Concentrate (Human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The effectiveness of RiaSTAP is based on maximum…